Large-scale testing (Phase 3)Ended earlyNCT01827930
What this trial is testing
Phase III Trial Evaluating the Effectiveness of a Dose Adjustment of Imatinib Mesylate on the Molecular Response
Who this might be right for
Leukemia, Myeloid, Chronic-Phase
Institut Bergonié 68